Cargando…

CKD: The burden of disease invisible to research funders

The uptake of the current concept of chronic kidney disease (CKD) by the public, physicians and health authorities is low. Physicians still mix up CKD with chronic kidney insufficiency or failure. In a recent manuscript, only 23% of participants in a cohort of persons with CKD had been diagnosed by...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040466/
https://www.ncbi.nlm.nih.gov/pubmed/36153901
http://dx.doi.org/10.1016/j.nefroe.2021.09.005
_version_ 1784694342727761920
collection PubMed
description The uptake of the current concept of chronic kidney disease (CKD) by the public, physicians and health authorities is low. Physicians still mix up CKD with chronic kidney insufficiency or failure. In a recent manuscript, only 23% of participants in a cohort of persons with CKD had been diagnosed by their physicians as having CKD while 29% has a diagnosis of cancer and 82% had a diagnosis of hypertension. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. A prevalent view is that for those in whom kidneys fail, the problem is “solved” by dialysis or kidney transplantation. However, the main burden of CKD is accelerated aging and all-cause and cardiovascular premature death. CKD is the most prevalent risk factor for lethal COVID-19 and the factor that most increases the risk of death in COVID-19, after old age. Moreover, men and women undergoing KRT still have an annual mortality which is 10–100-fold higher than similar age peers, and life expectancy is shortened by around 40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth global cause of death by 2040 and the second cause of death in Spain before the end of the century, a time when 1 in 4 Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded CIBER network research structure in Spain. Leading Spanish kidney researchers grouped in the kidney collaborative research network REDINREN have now applied for the RICORS call of collaborative research in Spain with the support of the Spanish Society of Nephrology, ALCER and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true. However, only the highest level of research funding through the CIBER will allow to adequately address the issue before it is too late.
format Online
Article
Text
id pubmed-9040466
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-90404662022-04-26 CKD: The burden of disease invisible to research funders Nefrologia (Engl Ed) Special Article The uptake of the current concept of chronic kidney disease (CKD) by the public, physicians and health authorities is low. Physicians still mix up CKD with chronic kidney insufficiency or failure. In a recent manuscript, only 23% of participants in a cohort of persons with CKD had been diagnosed by their physicians as having CKD while 29% has a diagnosis of cancer and 82% had a diagnosis of hypertension. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. A prevalent view is that for those in whom kidneys fail, the problem is “solved” by dialysis or kidney transplantation. However, the main burden of CKD is accelerated aging and all-cause and cardiovascular premature death. CKD is the most prevalent risk factor for lethal COVID-19 and the factor that most increases the risk of death in COVID-19, after old age. Moreover, men and women undergoing KRT still have an annual mortality which is 10–100-fold higher than similar age peers, and life expectancy is shortened by around 40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth global cause of death by 2040 and the second cause of death in Spain before the end of the century, a time when 1 in 4 Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded CIBER network research structure in Spain. Leading Spanish kidney researchers grouped in the kidney collaborative research network REDINREN have now applied for the RICORS call of collaborative research in Spain with the support of the Spanish Society of Nephrology, ALCER and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true. However, only the highest level of research funding through the CIBER will allow to adequately address the issue before it is too late. Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. 2022 2022-04-26 /pmc/articles/PMC9040466/ /pubmed/36153901 http://dx.doi.org/10.1016/j.nefroe.2021.09.005 Text en © 2021 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Special Article
CKD: The burden of disease invisible to research funders
title CKD: The burden of disease invisible to research funders
title_full CKD: The burden of disease invisible to research funders
title_fullStr CKD: The burden of disease invisible to research funders
title_full_unstemmed CKD: The burden of disease invisible to research funders
title_short CKD: The burden of disease invisible to research funders
title_sort ckd: the burden of disease invisible to research funders
topic Special Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040466/
https://www.ncbi.nlm.nih.gov/pubmed/36153901
http://dx.doi.org/10.1016/j.nefroe.2021.09.005
work_keys_str_mv AT ckdtheburdenofdiseaseinvisibletoresearchfunders
AT ckdtheburdenofdiseaseinvisibletoresearchfunders
AT ckdtheburdenofdiseaseinvisibletoresearchfunders
AT ckdtheburdenofdiseaseinvisibletoresearchfunders
AT ckdtheburdenofdiseaseinvisibletoresearchfunders
AT ckdtheburdenofdiseaseinvisibletoresearchfunders
AT ckdtheburdenofdiseaseinvisibletoresearchfunders
AT ckdtheburdenofdiseaseinvisibletoresearchfunders
AT ckdtheburdenofdiseaseinvisibletoresearchfunders